Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) Income towards Parent Company: 2019-2024

Historic Income towards Parent Company for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to -$21.7 million.

  • Mainz Biomed N.V's Income towards Parent Company rose 36.70% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 0.35%. This contributed to the annual value of -$21.7 million for FY2024, which is 17.82% up from last year.
  • Latest data reveals that Mainz Biomed N.V reported Income towards Parent Company of -$21.7 million as of FY2024, which was up 17.82% from -$26.3 million recorded in FY2023.
  • Mainz Biomed N.V's 5-year Income towards Parent Company high stood at -$586,895 for FY2020, and its period low was -$26.4 million during FY2022.
  • Its 3-year average for Income towards Parent Company is -$24.8 million, with a median of -$26.3 million in 2023.
  • Per our database at Business Quant, Mainz Biomed N.V's Income towards Parent Company soared by 38.68% in 2020 and then plummeted by 1,891.86% in 2021.
  • Yearly analysis of 5 years shows Mainz Biomed N.V's Income towards Parent Company stood at -$586,895 in 2020, then slumped by 1,891.86% to -$11.7 million in 2021, then tumbled by 125.72% to -$26.4 million in 2022, then climbed by 0.16% to -$26.3 million in 2023, then grew by 17.82% to -$21.7 million in 2024.